A phase III trial of taxotere and doxorubicin (AT) versus 5-fluorouracil, doxorubicin and cyclophosphamide (FAC) in patients with unresectable locally advanced breast cancer: an interim analysisK. Bouzid, Nabeel Badri, Fernando Palacios Salas et al.|European Journal of Cancer|2001Cited by 10